723
Views
20
CrossRef citations to date
0
Altmetric
Original

Regional hyperthermia of the abdomen in conjunction with chemotherapy for peritoneal carcinomatosis: Evaluation of two annular-phased-array applicators

, , , , , , , & show all
Pages 399-408 | Received 19 Aug 2007, Accepted 18 Jan 2008, Published online: 09 Jul 2009

References

  • Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124–132
  • Verwaal VJ, van Ruth S, de Bree E, van Slooten GW, van Tinteren H, Boot H, Zoetmulder FAN. Randomized trial of cytoreduction and hyperthermic introperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737–3743
  • De Bree E, Witkamp AJ, Zoetmulder FAN. Intraperitoneal chemotherapy for colorectal cancer. J Surg Oncol 2002; 79: 46–61
  • Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, Copeland LJ, Walker JL, Burger RA. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. New Engl J Med 2006; 354: 34–43
  • Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487–497
  • Jones E, Secord AA, Prosnitz LR, Samulski TV, Oleson JR, Berchuck A, Clarke-Pearson D, Soper J, Dewhirst MW, Vujaskovic Z. Intra-peritoneal cisplatin and whole abdomen hyperthermia for relapsed ovarian carcinoma. Int J Hyperthermia 2006; 22: 161–172
  • Hildebrandt B, Rau B, Gellermann J, Wust P, Riess H. Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis. J Clin Oncol 2004; 22(8)1527–1529
  • Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33–56
  • Dewhirst MW, Vujaskovic Z, JNones E, Thrall D. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 2005; 21: 779–790
  • Gellermann J, Wlodarczyk W, Ganter H, et al. A practical approach to perform the thermography in a hyperthermia/MR hybrid system - validation in an anthropomorphous phantom. Int J Radiat Oncol Biol Phys 2005; 61: 267–277
  • Wust P, Cho CH, Hildebrandt B, Gellermann J. Thermal monitoring: Invasive, minimal-invasive and non-invasive approaches. Int J Hyperthermia 2006; 22: 255–262
  • Sadeghi B, Arvieux C, Glehen O, Beaujard A, Rivoire M, Beaulieux J, et al. Peritoneal carcinomatosis from non-gynecological malignancies. Results of the EVOCAPE 1 multi-centric prospective study. Cancer 2000; 88: 58–63
  • Chu DZJ, Lang NP, Thomson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989; 63: 374–377
  • Fujimura T, Yonemura Y, Fujita H, Michiwa Y, Kawamura T, Nojima N, et al. Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intraabdominal malignancies. Int Surg 1999; 84: 60–66
  • Witkamp AJ, de Bree E, Kaag MM, Boot H, Beijnen JH, van Slooten GW, et al. Extensive cytoreductive surgery followed by intraoperative hyperthermic intraperitoneal chemotherapy with mitomycin C for colorectal cancer with peritoneal metastases. Eur J Cancer 2001; 37: 979–984
  • Elias D, Blot F, El Otmani A, Antoun S, Lasser P, Boige V, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 2001; 92: 71–76
  • Gertsch P. A historical perspective on colorectal liver metases and peritoneal carcinomatosis: Similar results, different treatments. Surg Oncol Clin N Am 2003; 12: 531–541
  • Trimble EL, Adams JD, Vena D, Hawkins MJ, Friedman MA, Fisherman JS, et al. Paclitaxel for platinum refractory ovarian cancer: Results from the first 1,000 patients registered to National Cancer Institute Referral center 9103. J Clin Oncol 1993; 11: 2405–2410
  • González-Martin A. Treatment of recurrent disease: Randomized trials of monotherapy versus combination chemotherapy. Int J Gynecol Cancer 2005; 15(Suppl. 3)241–246
  • Piccart MJ, Green JA, Lacave AJ, Reed N, Vergote I, Benedetti-Panici P, Bonetti A, et al. Oxaliplatin or paclitaxel in patients with platinum-pretreated advanced ovarian cancer: A ranzomized phase II study of the European Organization for Res. and Treatment of Cancer Gynecology Group. J Clin Oncol 2000; 18: 1193–1202
  • Gordon AN, Tonda M, Sun S, Rachoff W. 2004; 95: 1–8, on behalf of the Doxil Study 30–49 investigators. Gyn Oncol
  • Sreenivasa G, Gellermann J, Rau R, et al. Clinical application of the hyperthermia treatment planning system HyperPlan - comparison of algorithms and clinical observables. Int J Radiat Oncol Biol Phys 2003; 55: 407–419
  • Gellermann J, Weihrauch M, Cho CH, et al. Comparison of MR-thermography and planning calculations in phantoms. Med Phys 2006; 33: 3912–3920
  • Weihrauch M, Wust P, Weiser M, et al. Adaptation of antenna profiles for control of MR guided hyperthermia (HAT) in a hybrid system. Med Phys 2007; 34: 4717–4725

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.